# Blackstone Inc.: financial statements, quarterly

BX · NYSE · CIK 1393818 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bx.md) · [Financials](/companies/bx/financials.md) · [Filings](/companies/bx/filings.md) · [Insiders](/companies/bx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bx/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q1 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,541](/filings/0001193125-24-249809.md) | [1,285 d](/filings/0001193125-26-082531.md) | [3,688](/filings/0001193125-25-111595.md) | [2,796](/filings/0001193125-25-176984.md) | [3,663](/filings/0001193125-25-272343.md) | [3,083 d](/filings/0001193125-26-082531.md) | [3,289](/filings/0001193125-26-214609.md) | [3,712](/filings/0001193125-26-340208.md) | [3,089](/filings/0001193125-25-272343.md) | [4,360 d](/filings/0001193125-26-082531.md) | [3,618](/filings/0001193125-26-214609.md) | [5,044](/filings/0001193125-26-340208.md) |
| Interest expense | $m | [111](/filings/0001193125-24-249809.md) | [109 d](/filings/0001193125-26-082531.md) | [108](/filings/0001193125-25-111595.md) | [109](/filings/0001193125-25-176984.md) | [111](/filings/0001193125-25-272343.md) | [116 d](/filings/0001193125-26-082531.md) | [118](/filings/0001193125-26-214609.md) | [136](/filings/0001193125-26-340208.md) | [126](/filings/0001193125-25-272343.md) | [128 d](/filings/0001193125-26-082531.md) | [137](/filings/0001193125-26-214609.md) | [145](/filings/0001193125-26-340208.md) |
| Income tax | $m | [197](/filings/0001193125-24-249809.md) | [46.0 d](/filings/0001193125-26-082531.md) | [284](/filings/0001193125-25-111595.md) | [260](/filings/0001193125-25-176984.md) | [245](/filings/0001193125-25-272343.md) | [232 d](/filings/0001193125-26-082531.md) | [244](/filings/0001193125-26-214609.md) | [289](/filings/0001193125-26-340208.md) | [210](/filings/0001193125-25-272343.md) | [382 d](/filings/0001193125-26-082531.md) | [197](/filings/0001193125-26-214609.md) | [452](/filings/0001193125-26-340208.md) |
| Net income | $m | [552](/filings/0001193125-24-249809.md) | [152 d](/filings/0001193125-26-082531.md) | [847](/filings/0001193125-25-111595.md) | [444](/filings/0001193125-25-176984.md) | [781](/filings/0001193125-25-272343.md) | [704 d](/filings/0001193125-26-082531.md) | [615](/filings/0001193125-26-214609.md) | [764](/filings/0001193125-26-340208.md) | [625](/filings/0001193125-25-272343.md) | [1,015 d](/filings/0001193125-26-082531.md) | [650](/filings/0001193125-26-214609.md) | [1,229](/filings/0001193125-26-340208.md) |
| Diluted EPS | $ per share | [0.73](/filings/0001193125-24-249809.md) | not reported | [1.11](/filings/0001193125-25-111595.md) | [0.58](/filings/0001193125-25-176984.md) | [1.02](/filings/0001193125-25-272343.md) | not reported | [0.80](/filings/0001193125-26-214609.md) | [0.98](/filings/0001193125-26-340208.md) | [0.80](/filings/0001193125-25-272343.md) | not reported | [0.83](/filings/0001193125-26-214609.md) | [1.54](/filings/0001193125-26-340208.md) |
| Basic EPS | $ per share | [0.73](/filings/0001193125-24-249809.md) | not reported | [1.12](/filings/0001193125-25-111595.md) | [0.58](/filings/0001193125-25-176984.md) | [1.02](/filings/0001193125-25-272343.md) | not reported | [0.80](/filings/0001193125-26-214609.md) | [0.98](/filings/0001193125-26-340208.md) | [0.80](/filings/0001193125-25-272343.md) | not reported | [0.83](/filings/0001193125-26-214609.md) | [1.54](/filings/0001193125-26-340208.md) |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q1 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [3.0](/filings/0001193125-23-270358.md) | [3.0](/filings/0001193125-25-042469.md) | [2.5](/filings/0001193125-24-130670.md) | [2.4](/filings/0001193125-24-192846.md) | [2.4](/filings/0001193125-24-249809.md) | [2.0](/filings/0001193125-26-082531.md) | [2.4](/filings/0001193125-25-111595.md) | [2.2](/filings/0001193125-25-176984.md) | [2.4](/filings/0001193125-25-272343.md) | [2.6](/filings/0001193125-26-340208.md) | [2.4](/filings/0001193125-26-214609.md) | [2.5](/filings/0001193125-26-340208.md) |
| Total assets | $bn | [41.7](/filings/0001193125-23-270358.md) | [40.3](/filings/0001193125-25-042469.md) | [39.7](/filings/0001193125-24-130670.md) | [40.6](/filings/0001193125-24-192846.md) | [42.6](/filings/0001193125-24-249809.md) | [43.5](/filings/0001193125-26-082531.md) | [45.3](/filings/0001193125-25-111595.md) | [45.4](/filings/0001193125-25-176984.md) | [46.6](/filings/0001193125-25-272343.md) | [47.7](/filings/0001193125-26-340208.md) | [48.3](/filings/0001193125-26-214609.md) | [49.9](/filings/0001193125-26-340208.md) |
| Total liabilities | $bn | [22.9](/filings/0001193125-23-270358.md) | [22.2](/filings/0001193125-25-042469.md) | [21.2](/filings/0001193125-24-130670.md) | [21.9](/filings/0001193125-24-192846.md) | [23.1](/filings/0001193125-24-249809.md) | [24.0](/filings/0001193125-26-082531.md) | [25.4](/filings/0001193125-25-111595.md) | [24.3](/filings/0001193125-25-176984.md) | [25.2](/filings/0001193125-25-272343.md) | [25.8](/filings/0001193125-26-340208.md) | [26.9](/filings/0001193125-26-214609.md) | [27.5](/filings/0001193125-26-340208.md) |
| Long-term debt | $bn | [12.3](/filings/0001193125-23-270358.md) | [11.6](/filings/0001193125-24-044485.md) | [10.9](/filings/0001193125-24-130670.md) | [10.8](/filings/0001193125-24-192846.md) | [10.9](/filings/0001193125-24-249809.md) | [11.5](/filings/0001193125-25-042469.md) | [12.6](/filings/0001193125-25-111595.md) | [12.1](/filings/0001193125-25-176984.md) | [12.1](/filings/0001193125-25-272343.md) | [12.6](/filings/0001193125-26-082531.md) | [13.4](/filings/0001193125-26-214609.md) | [13.3](/filings/0001193125-26-340208.md) |
| Shareholders' equity | $bn | [7.1](/filings/0001193125-23-270358.md) | [6.8](/filings/0001193125-25-042469.md) | [7.0](/filings/0001193125-24-130670.md) | [6.8](/filings/0001193125-24-192846.md) | [7.0](/filings/0001193125-24-249809.md) | [8.2](/filings/0001193125-26-082531.md) | [8.0](/filings/0001193125-25-111595.md) | [8.4](/filings/0001193125-25-176984.md) | [8.4](/filings/0001193125-25-272343.md) | [8.7](/filings/0001193125-26-340208.md) | [8.4](/filings/0001193125-26-214609.md) | [9.0](/filings/0001193125-26-340208.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1,083 d](/filings/0001193125-24-249809.md) | [896 d](/filings/0001193125-26-082531.md) | [940](/filings/0001193125-25-111595.md) | [1,159 d](/filings/0001193125-25-176984.md) | [1,222 d](/filings/0001193125-25-272343.md) | [161 d](/filings/0001193125-26-082531.md) | [1,109](/filings/0001193125-26-214609.md) | [889 d](/filings/0001193125-26-340208.md) | [1,598 d](/filings/0001193125-25-272343.md) | [1,068 d](/filings/0001193125-26-082531.md) | [991](/filings/0001193125-26-214609.md) | [1,941 d](/filings/0001193125-26-340208.md) |
| Capital expenditure | $m | [62.7 d](/filings/0001193125-24-249809.md) | [31.3 d](/filings/0001193125-26-082531.md) | [17.8](/filings/0001193125-25-111595.md) | [12.4 d](/filings/0001193125-25-176984.md) | [19.4 d](/filings/0001193125-25-272343.md) | [11.9 d](/filings/0001193125-26-082531.md) | [29.3](/filings/0001193125-26-214609.md) | [40.1 d](/filings/0001193125-26-340208.md) | [23.9 d](/filings/0001193125-25-272343.md) | [22.4 d](/filings/0001193125-26-082531.md) | [33.4](/filings/0001193125-26-214609.md) | [32.0 d](/filings/0001193125-26-340208.md) |
| Dividends paid | $m | [1,039 d](/filings/0001193125-24-249809.md) | [1,039 d](/filings/0001193125-26-082531.md) | [1,177](/filings/0001193125-25-111595.md) | [1,088 d](/filings/0001193125-25-176984.md) | [1,071 d](/filings/0001193125-25-272343.md) | [1,088 d](/filings/0001193125-26-082531.md) | [1,859](/filings/0001193125-26-214609.md) | [1,215 d](/filings/0001193125-26-340208.md) | [1,342 d](/filings/0001193125-25-272343.md) | [1,598 d](/filings/0001193125-26-082531.md) | [1,918](/filings/0001193125-26-214609.md) | [1,529 d](/filings/0001193125-26-340208.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q1 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [742](/filings/0001193125-23-270358.md) | [747](/filings/0001193125-24-130670.md) | [759](/filings/0001193125-24-192846.md) | [758](/filings/0001193125-24-249809.md) | [760](/filings/0001193125-25-111595.md) | [769](/filings/0001193125-25-176984.md) | [768](/filings/0001193125-25-272343.md) | [772](/filings/0001193125-26-214609.md) | [782](/filings/0001193125-26-340208.md) | [783](/filings/0001193125-25-272343.md) | [786](/filings/0001193125-26-214609.md) | [800](/filings/0001193125-26-340208.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 750,625,114 at 2026-07-31, from the cover of the [10-Q filed 2026-08-07](/filings/0001193125-26-340208.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. No prices; not investment advice.